MRSN
|
Mersana Therapeutics, Inc.
|
0.33%
|
US
|
NASDAQ
|
ETNB
|
89bio, Inc.
|
0.32%
|
US
|
NASDAQ
|
CINC
|
CinCor Pharma, Inc.
|
0.31%
|
US
|
NASDAQ
|
HLVX
|
HilleVax, Inc.
|
0.30%
|
US
|
NASDAQ
|
CBAY
|
CymaBay Therapeutics Inc.
|
0.30%
|
US
|
NASDAQ
|
FULC
|
Fulcrum Therapeutics, Inc.
|
0.29%
|
US
|
NASDAQ
|
ALVR
|
AlloVir, Inc.
|
0.29%
|
US
|
NASDAQ
|
ALBO
|
Albireo Pharma, Inc.
|
0.29%
|
US
|
NASDAQ
|
IMAB
|
I-Mab
|
0.28%
|
US
|
NASDAQ
|
KZR
|
Kezar Life Sciences, Inc.
|
0.28%
|
US
|
NASDAQ
|
KOD
|
Kodiak Sciences Inc
|
0.28%
|
US
|
NASDAQ
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.27%
|
US
|
NASDAQ
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.25%
|
US
|
NASDAQ
|
ALDX
|
Aldeyra Therapeutics, Inc.
|
0.25%
|
US
|
NASDAQ
|
TARS
|
Tarsus Pharmaceuticals, Inc.
|
0.24%
|
US
|
NASDAQ
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
0.24%
|
US
|
NASDAQ
|
BCAB
|
BioAtla, Inc.
|
0.23%
|
US
|
NASDAQ
|
AURA
|
Aura Biosciences, Inc.
|
0.23%
|
US
|
NASDAQ
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
0.22%
|
US
|
NASDAQ
|
TERN
|
Terns Pharmaceuticals, Inc.
|
0.21%
|
US
|
NASDAQ
|